Patient Guide: EPIC-ATTR: A Study to Evaluate the Effect of Eplontersen on the Transthyretin Reduction and Long-term Safety in Chinese Subjects With Transthyretin Amyloid Cardiomyopathy

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 26 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06194825
Status: ACTIVE_NOT_RECRUITING
Condition: Transthyretin Amyloid Cardiomyopathy
Phase: PHASE3

Find a Study Location Near You

This study is available at 26 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Beijing,
  • Beijing,
  • Beijing,
  • • And 23 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily